Citation: | DU Minjuan, XU Xiaoguang, LIU Ruiqi, YANG Yaqin, JIANG Yingchao, WU Lil. Effect of Hinokitiol Combined with Chloroquine on Apoptosis of Human Lung Adenocarcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 970-973. DOI: 10.3971/j.issn.1000-8578.2015.10.004 |
[1] |
Liu F, Yu G, Wang G, et al. An NQO1-initiated and p53- independent apoptotic pathway determines the anti-tumor effect of tanshinoneⅡA against non-small cell lung cancer[J]. PLoS One, 20 12, 7(7): e42138.
|
[2] |
Rogerio AP, Andrade EL, Leite DF, et al. Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation[J]. Br J Pharmacol, 2009, 158(4): 1074-87.
|
[3] |
Darmanin S, Wismayer PS, Camilleri Podesta MT, et al. An extract from Ricinus communis L. leaves possesses cytotoxic properties and induces apoptosis in SK-MEL-28 human melanoma cells[J]. Nat Prod Res, 2009, 23(6): 561-71.
|
[4] |
Bhalla Y, Gupta VK, Jaitak V. Anticancer activity of essential oils: a review[J]. J Sci Food Agric, 2013, 93(15): 3643-53.
|
[5] |
Toshihiro OKABE, Kouji SAITO. Antibacterial and preservative effects of natural Hinokitiol(β-Thujaplicin) extracted from wood[J]. Zhejiang Nong Ye Xue Bao, 1994, 6(4): 257-66. [Toshihiro OKABE, Kouji SAITO. 树木中提取的天然扁柏醇的 抗菌和保鲜效果[J]. 浙江农业学报, 1994, 6(4): 257-66.]
|
[6] |
Li LH, Wu P, Lee JY, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells[J]. PLoS One, 2014, 9( 8): e104203.
|
[7] |
Shih MF, Chen LY, Tsai PJ, et al. In vitro and in vivo therapeutics of beta-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice[J]. Int J Immunopathol Pharmacol, 2012, 25 (1): 39-48.
|
[8] |
Morita Y, Matsumura E, Okabe T, et al. Biological activity of alpha-thujaplicin, the isomer of hinokitiol[J]. Biol Pharm Bull, 20 04, 27(6): 899-902.
|
[9] |
Komaki N, Watanabe T, Ogasawara A, et al. Antifungal mechanism of hinokitiol against Candida albicans[J]. Biol Pharm Bull, 2008, 31 (4): 735-7.
|
[10] |
Budihas SR, Gorshkova I, Gaidamakov S, et al. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones[J]. Nucleic Acids Res, 20 05, 33(4): 1249-56.
|
[11] |
Liu S, Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines[J]. Biochem Biophys Res Commun, 2006, 351(1): 26-32.
|
[12] |
Shih YH, Chang KW, Hsia SM, et al. In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines[J]. Microbiol Res, 2013, 168(5): 254-62.
|
[13] |
Lee YS, Choi KM, Kim W, et al. Hinokitiol inhibits cell growth through induction of S-phase arrest and apoptosis in human colon cancer cells and suppresses tumor growth in a mouse xenograft experiment[J]. J Nat Prod, 2013, 76(12): 2195-202.
|
[14] |
Calderón-Montaño JM, Burgos-Morón E, Orta ML, et al. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death[J]. Pharmacol Rep, 2012, 64(6): 1515-25.
|
[15] |
Hisatomi T, Sueoka-Aragane N, Sato A, et al. NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase Ⅱ{alpha} and DNAdependent protein kinase[J]. Blood, 2011, 117(13): 3575-84.
|
[16] |
Levy JM, Thorburn A.Targeting autophagy during cancer therapy to improve clinical outcomes[J]. Pharmacol Ther, 2011, 131(1): 13 0-41.
|
[17] |
Kimura T, Takabatake Y, Takahashi A, et al. Chloroquine in cancer therapy: a double-edged sword of autophagy[J]. Cancer Res, 20 13, 73(1): 3-7.
|
[1] | LIU Hong, BIAN Lei, FANG Zhaohui, ZHANG Qianying, ZHU Hongwei, CHENG Jianxin. Characteristics of CD44 and CD24-marked Cervical Cancer Cells Subgroups[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 345-349. DOI: 10.3971/j.issn.1000-8578.2016.05.006 |
[2] | He Aina, Qi Weixiang, Tang Li′na, Shen Zan, Sun Yuanjue, Chen Jie, Yao Yang. Expression and Clinical Significance of CD133 and CD44 in Osteosarcoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(11): 1328-1332. DOI: 10.3971/j.issn.1000-8578.2012.11.012 |
[3] | WU Ming, LI Xue-jun, LI Zhen-yan, CHENG Lei, TANG Zhi, YUAN Xian-rui. Downregulation of Expression of Moesin in U251 Cells after Transfection with siRNA Leads PDGF and CD44 to Decrease[J]. Cancer Research on Prevention and Treatment, 2011, 38(02): 121-125. DOI: 10.3971/j.issn.1000-8578.2011.02.001 |
[4] | WANG Jing, LV Ke-jie, ZHU Guang-chang. Application of Serum DNA and hTERT in Diagnose of Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 656-658. DOI: 10.3971/j.issn.1000-8578.2624 |
[5] | LI Ying-jie, TAO Xiao-feng, HE Yan, FU Hong. Expression and Correlation of Ezrin and CD44 in Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2008, 35(03): 188-190. DOI: 10.3971/j.issn.1000-8578.1834 |
[6] | TONG Shu-lan, YIN Mei-ying, FEI Shao-hua, YI Long-zheng, YANG Ling-fang, SUN Hong-fu. Expression of ER、PR、p53 and DNA Content in Gallbladder Carcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(03): 158-160. DOI: 10.3971/j.issn.1000-8578.143 |
[7] | FAN Zai-wen, WAN Yi-xin, AN ZHen-guang, et al. Study on expression of Bcl-2 and CD44 in human lung cancer[J]. Cancer Research on Prevention and Treatment, 2002, 29(05): 373-375. DOI: 10.3971/j.issn.1000-8578.820 |
[8] | ZHENG Wei, HUANG Jian-wen. Study on the Nuclear DNA Content in the Giant Cell Tumor of Bone by Image Cytometer[J]. Cancer Research on Prevention and Treatment, 2000, 27(02): 101-102. DOI: 10.3971/j.issn.1000-8578.2188 |
[9] | Wang Zhanxiang, . Study on the correlations of cellular DNA content with benign and malignant tumors of central nervous system[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 455-456. |
[10] | Yang Ying, . The investigate of DNA contents in colorectal cancer[J]. Cancer Research on Prevention and Treatment, 1998, 25(1): 29-30. |